Company Concord Drugs Limited

CONCORD6

INE858L01010

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-05-31 EDT			5-day change	1st Jan Change
37.03 ^INR	-2.37%		-5.92%	-37.99%

03-19	Concord Drugs Limited Announces Appointment of Namratha Nagla as Company Secretary/Compliance Officer	CI
02-13	Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Concord Drugs Limited is an India-based pharmaceutical company. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup and suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellet system (MUPS). Its injectables include Amikacin Injection, Aceclofenac Injection, Artemether Injection, Adenosine Injection, and others. Iso Amyl 2-Cyano Acrylate is a tissue bio-adhesive. Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, and others.

Number of employees: 185

Managers	Title	Age	Since
Nagi Reddy Seelam CEO	Chief Executive Officer	54	03-04-03
Seelam Koni Reddy DFI	Director of Finance/CFO	35	11-06-09

Members of the board	Title	Age	Since
Nagi Reddy Seelam CEO	Chief Executive Officer	54	03-04-03
Kommula Ramachandra Reddy BRD	Director/Board Member	63	95-04-23
Seelam Koni Reddy DFI	Director of Finance/CFO	35	11-06-09
S. Nagavenkata Hareesh BRD	Director/Board Member	-	21-02-12
S. Manoj Kumar Reddy BRD	Director/Board Member	-	21-08-12
K. Sumeela BRD	Director/Board Member	-	22-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,000,000	2,974,232 ( 29.74 %)	0	29.74 %

Concord Drugs Ltd.

Survey No.249, Brahmanapally Village Hayatnagar Mandal

501511, Hyderabad

+91 40 2403 6379

http://www.concorddrugs.in

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
CONCORD DRUGS LIMITED	-37.99%	4.44M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals